Navigation Links
New player in commitment to life as a fat cell

Researchers have discovered a pivotal new player in early events that commit fat cell precursors to becoming full-blown fat, according to a report in the February issue of the journal Cell Metabolism, published by Cell Press. Drugs that block some activities of the enzyme, known as xanthine oxidoreductase (XOR), might therefore offer a novel antiobesity therapy designed to fight fat before it even forms, the researchers said.

Known for its role in producing the metabolic byproduct uric acid, XOR had earlier been implicated in gout, said Jeffrey Friedman of The Rockefeller University, senior author of the study. Gout is a painful type of arthritis that results when uric acid crystals build up in the joints.

"These findings are novel in many aspects," said Iphigenia Tzameli of Harvard Medical School, one of the study's first authors. "This enzyme was originally known in association with the catabolism of purines into uric acid, the production of reactive oxygen species, and its involvement in gout. It has never been looked at in the context of fat development before."

The findings further suggest that adipose-tissue XOR may be a contributing factor to other symptoms commonly seen in obese individuals, including high blood levels of uric acid (hyperuricemia), the presence of plaque-forming lipids, and oxidative stress, the researchers added.

The research team, which also included Kevin Cheung of The Rockefeller University, screened fat precursor cells for genes that switch on early in the path to fat formation. Using a novel method to rank genes, they found that XOR was at the top of the list of genes that fit the profile of a fat generator.

Indeed, they found evidence that XOR controls PPAR-gamma a transcription factor considered to be the master regulator of fat production since it is both necessary and sufficient for adipose differentiation both in vitro and in vivo, the researchers said.

Treatments that inhib ited XOR activity in cells blocked fat formation and PPAR-gamma activity, the researchers reported. Likewise, increased XOR levels hiked activity of the PPAR-gamma receptor in both fat cells and fat cell precursors. Mice lacking XOR showed a 50% reduction in fat tissue mass compared to their normal littermates. Genetically obese mice exhibited increased XOR activity and urate in the adipose tissue. Urate is a salt derived from uric acid.

"Our results identify XOR as a potential therapeutic target for metabolic abnormalities beyond hyperuricemia," the researchers said.

"To our knowledge, there have not been studies designed to explore the effects of XOR inhibitors on body weight, and in light of our findings, such studies may be warranted," they added.
'"/>

Source:Cell Press


Related biology news :

1. Virginia Tech football player uses prototype cast
2. Scientist measures role of sciences coolest player: The snow
3. Common enzyme is a key player in DNA repair
4. Birth rate, competition are major players in hominid extinctions
5. Brown cancer biologists identify major player in cell growth
6. The very unexpected life and death of a leukemic cell
7. Scientists reveal how disease bacterium survives inside immune system cell
8. Scientists devise way to measure RNA synthesis on the fly in a live cell
9. The making of a fat cell
10. Einstein scientists discover how protein crucial for motion is synthesised at the right place in the cell
11. Researchers identify new cord blood stem cell

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... March 22, 2017 Oramed Pharmaceuticals Inc. ... www.oramed.com ), a clinical-stage pharmaceutical ... delivery systems, announced today that Dr. Miriam ... a presentation titled, "Oral Insulin for Diabetes Treatment: ... Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... March 22, 2017   Boston Biomedical , an ... designed to target cancer stemness pathways, today announced its ... as Chief Executive Officer, effective April 24, 2017. ... J. Li , M.D., FACP, who has led Boston ... Under his leadership, Boston Biomedical has grown from a ...
(Date:3/22/2017)... (PRWEB) , ... March 21, 2017 , ... Benchworks ... Science Chief Executive Officer Forum on March 23-24 in San Diego. The event ... device and diagnostic industries. , Benchworks Vice President Christian Meyer will also participate ...
Breaking Biology Technology: